Related references
Note: Only part of the references are listed.The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes
Matthew D. Hall et al.
CANCER RESEARCH (2014)
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2014)
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer
Valentina Gandin et al.
CHEMMEDCHEM (2014)
Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2014)
Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformations
Ying Song et al.
BIOCONJUGATE CHEMISTRY (2013)
Redox activation of metal-based prodrugs as a strategy for drug delivery
Nora Graf et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
IKK-β mediates chemoresistance by sequestering FOXO3; A critical factor for cell survival and death
Tugsan Tezil et al.
CELLULAR SIGNALLING (2012)
Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs
Hristo P. Varbanov et al.
DALTON TRANSACTIONS (2012)
Solvolysis of a Series of Cisplatin-Like Complexes - Comparison between DNA-Biosensor and Conductivity Data
James A. Platts et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation
Chee Fei Chin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes
Ding-Wu Shen et al.
PHARMACOLOGICAL REVIEWS (2012)
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin
Hristo Varbanov et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
The design and screening of drugs to prevent acquired sensorineural hearing loss
Debashree Mukherjea et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
Justin J. Wilson et al.
INORGANIC CHEMISTRY (2011)
Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes
Michael R. Reithofer et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Ethanesulfohydroxamic Acid Ester Prodrugs of Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Synthesis, Nitric oxide and Nitroxyl Release, Cyclooxygenase Inhibition, Anti-inflammatory, and Ulcerogenicity Index Studies
Zhangjian Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Celecoxib Antagonizes the Cytotoxicity of Cisplatin in Human Esophageal Squamous Cell Carcinoma Cells by Reducing Intracellular Cisplatin Accumulation
Le Yu et al.
MOLECULAR PHARMACOLOGY (2011)
Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents
Md. Jashim Uddin et al.
CANCER RESEARCH (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
COX-2 as a target for cancer chemotherapy
Nilanjan Ghosh et al.
PHARMACOLOGICAL REPORTS (2010)
Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid
Jeffery J. Prusakiewicz et al.
BIOCHEMISTRY (2009)
Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation
Ozgur Kutuk et al.
CARCINOGENESIS (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
The COXIB Experience: A Look in the Rearview Mirror
Lawrence J. Marnett
Annual Review of Pharmacology and Toxicology (2008)
Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels
Marcel N. A. Bijman et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Stepwise assembly of platinum - folic acid conjugates
Elisabetta Gabano et al.
INORGANICA CHIMICA ACTA (2008)
Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity
Michael R. Reithofer et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-K-2 N,N '] platinum(II) complexes
Weiping Liu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity
Stephanie J. Fischer et al.
NEUROTOXICOLOGY (2008)
Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination
Michael R. Reithofer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake
Steven P. Oldfield et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates
Jinchao Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells
Amber P. Barnes et al.
GYNECOLOGIC ONCOLOGY (2007)
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes
David F. V. Lewis et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2006)
Signalling networks regulating cyclooxygenase-2
Christos Tsatsanis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake
WH Ang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives
L Habala et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Rapid up-regulation of cyclooxygenase-2 by 5-fluorouracil in human solid tumors
SJ Mercer et al.
ANTI-CANCER DRUGS (2005)
Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities
SS Byun et al.
BJU INTERNATIONAL (2005)
Mechanisms of platinum drug resistance
M Ohmichi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
WH Ang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway
YJ Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer
G Ferrandina et al.
CLINICAL CANCER RESEARCH (2004)
Role of caspases-3 and-7 in Apaf-1 proteolytic cleavage and degradation events during cisplatin-induced apoptosis in melanoma cells
B Del Bello et al.
EXPERIMENTAL CELL RESEARCH (2004)
Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition
DL Simmons et al.
PHARMACOLOGICAL REVIEWS (2004)
Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes
YE Kwon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
The first examples of platinum amine hydroxamate complexes: structures and biological activity
TW Failes et al.
DALTON TRANSACTIONS (2003)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
G Ferrandina et al.
ANNALS OF ONCOLOGY (2002)
Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action
GM Li et al.
LABORATORY INVESTIGATION (2002)
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients
G Ferrandina et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
Synergistic effect of indomethacin with adriamycin and cisplatin on tumor growth
K Hattori et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Mechanisms of resistance to cisplatin
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Structure-activity relationship of P-glycoprotein substrates and modifiers
A Seelig et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Synthesis and characterization of Pt(II) complexes with amine and carboxylato ligands.: Crystal structure of (1,1-cyclobutanedicarboxylato)di(ethylamine)platinum(II)•H2O
FD Rochon et al.
INORGANICA CHIMICA ACTA (2000)
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors
AS Kalgutkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer
DW Knapp et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Kinetics and mechanism for reduction of oral anticancer platinum(IV) dicarboxylate compounds by L-ascorbate ions
K Lemma et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
Share Paper
